IP Library Granted Patent US 10,883,996
Granted Patent B2
US 10,883,996 · App. 15/736,336 · Granted Jan 5, 2021

Methods of identifying signaling modulators of the trimeric TNFa

Inventors: James Philip O'Connell (Slough, GB); John Robert Porter (Slough, GB); Alastair Lawson (Slough, GB); Boris Kroeplien (Slough, GB); Stephen Edward Rapecki (Slough, GB); Timothy John Norman (Slough, GB); David James McMillan (Slough, GB); Graham John Warrellow (Slough, GB); Daniel Christopher Brookings (Slough, GB); Rikki Peter Alexander (Slough, GB)
Assignee: UCB BIOPHARMA SRL
G01N33/6845A61K47/6425A61P35/00A61P37/00C07D213/72C07D235/04C07D239/26C07D401/14C07D471/00C07D471/04C07K14/525C07K14/70575C07K16/241G01N33/6854G01N33/6863C07K2317/55C07K2317/92G01N2333/525G01N2500/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,883,996
App. No.
15/736,336
Granted
Jan 5, 2021
Kind
B2
Abstract

The invention is in the field of TNF signalling. Compounds have been identified which are capable of modulating signalling of TNF trimers through receptors. Methods of identifying such compounds are therefore provided. The compounds themselves have utility in therapy.

Claims (12)

1. A method of identifying a compound that binds to trimeric TNFα and modulates signalling of the trimeric TNFα through a TNF receptor, the method comprising determining the average number of receptors bound per trimer-compound complex in comparison with a control, wherein the average number of receptors bound per trimer-compound complex is determined by:

(i) ion mobility mass spectrometry;

(ii) size exclusion chromatography;

(iii) Förster Resonance Energy Transfer;

(iv) crystallography; or

(v) a combination thereof, wherein:

(a) the control comprises trimeric TNFα and TNF receptors in the absence of the compound, wherein a decrease in the average number of receptors bound per trimer-compound complex in comparison with the control identifies that the compound modulates signalling through the receptor; or

(b) the control comprises trimeric TNFα and TNF receptors, and a compound which is known to modulate signalling of the trimers through the receptors and an equivalent average number of receptors bound per trimer-compound complex in comparison with the control, or decrease in the average number of receptors bound per trimer-compound complex in comparison with the control, identifies that the compound modulates signalling through the receptor.

2. The method of claim 1 , wherein the average number of receptors bound per trimer-compound complex is determined at a molar ratio of between 3:1 and 10:1 (receptors:trimers).

3. The method of claim 1 , wherein a compound is identified as modulating signalling of the trimeric TNFα through the receptor if an average of less than three receptors are determined to be bound per trimer-compound complex.

4. The method of claim 3 , wherein a compound is identified as modulating signalling of the trimeric TNFα through the receptor if an average of two receptors are determined to be bound per trimer-compound complex.

5. The method of claim 3 , wherein a compound is identified as modulating signalling of the trimeric TNFα through the receptor if an average of one receptor is determined to be bound per trimer-compound complex.

Assignments (5)
CHANGE OF NAME Recorded Sep 2, 2020
From: UCB BIOPHARMA SPRL
To: UCB BIOPHARMA SRL
Reel/Frame 053670/0288 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 3, 2018
From: O'CONNELL, JAMES PHILIP; PORTER, JOHN ROBERT; LAWSON, ALASTAIR; KROEPLIEN, BORIS; RAPECKI, STEPHEN EDWARD; NORMAN, TIMOTHY JOHN; MCMILLAN, DAVID JAMES; WARRELLOW, GRAHAM JOHN; BROOKINGS, DANIEL CHRISTOPHER; ALEXANDER, RIKKI PETER
To: CELLTECH R&D LIMITED
Reel/Frame 046262/0722 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 3, 2018
From: CELLTECH R&D LIMITED
To: UCB S.A.
Reel/Frame 046262/0735 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 3, 2018
From: UCB S.A.
To: UCB PHARMA S.A.
Reel/Frame 046262/0782 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 3, 2018
From: UCB PHARMA S.A.
To: UCB BIOPHARMA SPRL
Reel/Frame 046262/0806 →
Priority Claims (1)
GB 1510758.4 · Jun 18, 2015 · national
Continuity (1)
Related Publication 20180203016A1 · Jul 19, 2018
Cited By (1)
US 12,474,348